MR technology provider Invivo has unveiled ONCAD, a fully-automated, morphological system for use in detecting and analyzing suspicious breast lesions.
ONCAD for DynaCAD uses a patented mathematical algorithm to analyze the entire breast and direct the physician's attention to abnormal morphology during contrast-enhanced breast MRI exams, the Gainesville, FL-based company said.
Suspicious lesions are marked with an intensity-specific color overlay: light pink for those of slight concern, and darker pink for highly suspect lesions.
The system has received U.S. Food and Drug Administration (FDA) clearance, Invivo said.
Related Reading
Invivo debuts MR prostate offerings, August 11, 2009
Invivo touts DynaSuite Neuro, November 13, 2008
Invivo to show enhanced monitor at RSNA, November 3, 2008
Invivo aids in conjoined twin procedure, January 23, 2008
Road to RSNA, CAD, Invivo, November 1, 2007
Copyright © 2009 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
